These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 18388801)
1. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies. Racke MK Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801 [TBL] [Abstract][Full Text] [Related]
2. B cells in spontaneous autoimmune diseases of the central nervous system. Berer K; Wekerle H; Krishnamoorthy G Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219 [TBL] [Abstract][Full Text] [Related]
3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy? Lee DH; Linker RA Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461 [TBL] [Abstract][Full Text] [Related]
4. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Stinissen P; Raus J Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096 [TBL] [Abstract][Full Text] [Related]
5. B cells and antibodies in MS. Reindl M; Kuenz B; Berger T Results Probl Cell Differ; 2010; 51():99-113. PubMed ID: 19513636 [TBL] [Abstract][Full Text] [Related]
7. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. Ichikawa M; Johns TG; Liu J; Bernard CC J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946 [TBL] [Abstract][Full Text] [Related]
9. B cells and multiple sclerosis. Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007 [TBL] [Abstract][Full Text] [Related]
10. B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data. Hawker K Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S19-25. PubMed ID: 18388796 [TBL] [Abstract][Full Text] [Related]
11. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303 [TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. De Santi L; Annunziata P; Sessa E; Bramanti P J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606 [TBL] [Abstract][Full Text] [Related]